Ms Contin
NDC Package 42858-799-01
Package Information
Ms Contin is indicated for the management of severe and persistent pain that requires an opioid analgesic and that cannot be adequately treated with alternative options, including immediate-release opioids.Limitations of UseBecause of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration and persist over the course of therapy [see Warnings and Precautions (5.2)], reserve opioid analgesics, including MS CONTIN, for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain.MS CONTIN is not indicated as an as-needed (prn) analgesic. Marketed by Rhodes Pharmaceuticals Llc, this product is identified by NDC 42858-799 and is authorized under FDA application NDA019516.
Identification & Billing
- RxCUI: 891881 - morphine sulfate 15 MG Extended Release Oral Tablet
- RxCUI: 891881 - MS 15 MG Extended Release Oral Tablet
- RxCUI: 891888 - morphine sulfate 30 MG Extended Release Oral Tablet
- RxCUI: 891888 - MS 30 MG Extended Release Oral Tablet
- RxCUI: 891893 - morphine sulfate 60 MG Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 42858 - Rhodes Pharmaceuticals Llc
- 42858-799 - Ms Contin
- 42858-799-01 - 100 TABLET in 1 BOTTLE, PLASTIC
- 42858-799 - Ms Contin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 42858-799-01 identifies a specific commercial package of 100 tablet in 1 bottle, plastic of Ms Contin, labeled by Rhodes Pharmaceuticals Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rhodes Pharmaceuticals Llc on May 15, 2017. The current certification is valid through August 17, 2026.
How is this Rhodes Pharmaceuticals Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 42858079901. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.